MKI67 and neoplasm: In vivo, the CUMA anti-tumor effect was observed together with a significant reduction in tumor cell proliferation as detected by Ki67 positive staining regardless of the dose used, and a similar effect was observed in CUMA50+PLX4032 treatment (Figure 4E).